L. Cao

Comparing nanoparticle polymeric micellar paclitaxel and solvent-based paclitaxel as first-line treatment of advanced non-small-cell lung cancer: an open-label, randomized, multicenter, phase III trial

Meiqi Shi, Hai‐Yan Tu, Cheng Huang et al. · Annals of Oncology · 2020 · 71 citations · Full text

Medicine, Oncology, Pharmacology +17

LBA4 GEMSTONE-302: A phase III study of platinum-based chemotherapy (chemo) with placebo or CS1001, an anti-PDL1 antibody, for first-line (1L) advanced non-small cell lung cancer (NSCLC)

Caicun Zhou, Z. Wang, Yehuan Sun et al. · Annals of Oncology · 2020 · 29 citations

Medicine, Oncology, Pharmacology +14

Keynote-407 China Extension study: Pembrolizumab (pembro) plus chemotherapy in Chinese patients with metastatic squamous NSCLC

Ying Cheng, L. Zhang, Jie Hu et al. · Annals of Oncology · 2019 · 20 citations · Full text

Medicine, Oncology, Pharmacology +9